Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates.
Petillon C, Ulutuipalelei M, Beyrouthy R, Proust S, Aissa N, Bret L, Brieu N, Carricajo A, Cattoir V, Dauwalder O, Degand N, Dortet L, Doucet-Populaire F, Dubois V, Grillon A, Guérin F, Lanotte P, Lemaitre N, Leyssene D, Neuwirth C, Patry I, Ploy MC, Podglajen I, Recule C, Rouis K, Réseau O, Robert J, Bonnet R, Robin F.
Petillon C, et al. Among authors: leyssene d.
Diagn Microbiol Infect Dis. 2025 Nov;113(3):117011. doi: 10.1016/j.diagmicrobio.2025.117011. Epub 2025 Jul 15.
Diagn Microbiol Infect Dis. 2025.
PMID: 40683213